Media preparation
Instructions for processing reagents
Complete RPMI (cRPMI) Supplement sterile RPMI-1640 medium with 10% sterile heat-inactivated FBS and 1% sterile antibiotic/antimycotic. Store at 4
• C.
Protocol
Processing of fresh PBMCs isolation 1. Collect blood via venipuncture directly into CPT tube(s). 2. Store CPT tube(s) at room temperature if they cannot be processed immediately; cell degradation will occur if tubes are stored for more than four hours. 3. Centrifuge CPT tube(s) at 1800 × g (approximately 2800 rpm on a Sorvall RT6000 centrifuge) for 20 minutes at room temperature. Be sure that the tubes are not loaded in the outer positions of the carriers, as this may cause the rubber tops of the tubes to contact the rotor and come off. 4. After centrifugation, bring the CPT tube(s) to a biological safety cabinet and carefully open the tops. Using a 5 ml pipette, gently pipette the plasma up and down against the gel plug to dislodge cells that are stuck to the top of the gel. Avoid vigorous pipetting that would disintegrate the gel plug itself. 5. Transfer the cell suspension from the CPT tube(s) to a 50 ml conical polypropylene tube, pooling the cells from each tube if there are multiple CPT tubes per donor. Add cRPMI to a total of 40 ml. 6. Remove a 10 ml aliquot of cell suspension for counting as per Cell Counting With a Hematocytometer, and Determining Cell Viability With Trypan Blue section, following. 7. Centrifuge 50 ml tubes at 250 × g (approximately 1200 rpm on a Sorvall RT6000 centrifuge) for seven minutes at room temperature. 8. Count cells with hematocytometer while tubes are centrifuging. 9. When centrifugation is complete, aspirate the supernatant and gently flick the tube with a finger to break up the pellet. Cell counting with a hematocytometer, and determining cell viability with trypan blue Note: Trypan blue is one of several stains recommended for use in dye exclusion procedures for viable cell counting. This method is based on the principle that live (viable) cells will not take up certain dyes, whereas dead (non-viable) cells will.
1 Mix 10 ul of cell suspension with 10 ul of 0.4% trypan blue. Allow dilution to incubate for three to five minutes at room temperature. 2 Inject 10 ul of the trypan blue/cell mixture beneath the cover slip on a hematocytometer. This volume will ensure that the hematocytometer is not overfilled. Place the hematocytometer on the stage of a binocular microscope and focus on the cells. 3 Count the unstained (viable) and stained (non-viable) cells from the central large square of the hemacytometer.
This square should just fill the field of view when using the 10 × lens. If the total cell count is less than 50, count additional large squares until between 50 and 100 cells have been counted. 4 Calculate the total number of viable cells as follows:
Total # viable cells = # viable cells per square × 2 (dilution factor) × 10,000 × total volume cell suspension (in ml) 5 Calculate the percentage of viable cells as follows:
6 Rinse the hemacytometer and cover slide with 70% alcohol, and wipe dry.
Cryopreservation of PBMCs
The following protocol for freezing PBMCs uses a final concentration of 10% dimethylsulfoxide (DMSO) and 90% protein (human serum albumin). Cryoprotectants, such as DMSO, reduce the amount of ice present during freezing and reduce solute concentration, thus reducing ionic stress. However, these compounds can themselves cause osmotic injury since they are hypertonic and can cause damage during their addition or removal.
1. Resuspend PBMCs (from Isolation section of Processing of Fresh PBMCs, above) at 1 × 107 viable lymphocytes/ml in 4 • C of FCS in a 10 ml conical polypropylene tube. 2. While gently swirling the tube, add dropwise enough 4
• C 2 × freezing medium (20% DMSO + FCS) to double the volume of the cell suspension. 3. Immediately place the tube on ice. Avoid any further mixing or agitation of the cells. Slowly remove the cell suspension into a pipet and dispense 1 ml per cryovial on ice. 4. Place the cryovials at -80
• C keeping air spaces between the vials. Transfer to Liq N2 the next day.
Day 0: Pre-coating TC plates 1. Precoat 6 well plate (one plate per patient) with hCD3 antibody at 5 ug/mL in PBS (filtered) at 37 • C × 2 hrs 2. Remove precoat solution and apply block solution of 2% BSA in PBS (filtered) at 37
• C × 30 mins 3. Remove block and wash w PBS × 3
Thawing of PBMCs
If PBMCs are not thawed properly, viability and cell recovery can be compromised; and cells may not perform optimally in functional assays. In general, cells should be thawed quickly but diluted slowly to remove DMSO. Cells with DMSO intercalated into their membranes are very fragile, and must be pelleted and handled gently.
1. Keep DMEM/IMDM at RT before beginning thawing procedure. 2. Transfer the cryovial from liquid nitrogen to a 37
• C water bath. If liquid nitrogen has seeped into the cryovial, loosen the cap slightly to allow the nitrogen to escape during thawing. Blood -SeV derived fibroblast generated iPSCs 3. Hold the cryovial in the surface of the water bath with an occasional gentle "flick" during thawing. Do not leave the cryovial unattended during the thawing process. It is important for cell viability that the cells are thawed and processed quickly; thawing takes only a minute or two. When a small bit of ice remains in the cryovial, transfer the cryovial to the biosafety hood. Dry off the outside of the cryovial and wipe with disinfectant before opening to prevent contamination. 4. Add warm DMEM/IMDM dropwise into the cryovial containing the cell suspension, slowly over a 30 second period. The final volume should be twice the volume of the cell suspension (e.g., add 1 ml cRPMI to a cryovial containing 1 ml cell suspension). Be careful not to exceed the capacity of the cryovial. 5. Transfer the diluted cell suspension to a 15 ml polypropylene centrifuge tube containing 8 ml of warm DMEM/ IMDM for every vial of cells added (multiple cryovials from the same donor may be combined into one 15 or 50 ml tube, if desired). 6. Centrifuge the cells at 1200 rpm (250 G) for five minutes. Aspirate media carefully. If pellet is not clearly defined then do not aspirate completely. Rather, do an additional wash and spin step with wash media 7. Resuspend cell pellet in 0.5-1 mL of LGM media (Lonza Clonetics CC3211) supplemented with 50 ngs/mL IL2 (90 U/ml.; Conversion 1 ug = 1800 IU) and 0.4 ugs/mL CD3 and CD28, + P/S + Glu 8. Remove 10 uL of suspension and dilute 1:10 in 0.1% eosin/Trypan Blue to do cell count. Count all 5 squares. 9. Plate 1.5-5×10 6 cells/well, 2 mL per well. For cell density >4×10 6 add a little extra media 
